Top Abstract Purchase Related
Home
>
Node
>
Subnode

A strategy for second-line anti-Helicobacter pylori therapy in patients with previously failed treatment

Ohkusa, T.; Watanabe, M.

Nihon Rinsho. Japanese Journal of Clinical Medicine 59(2): 323-327

2001

ISSN/ISBN: 0047-1852
PMID: 11218406
Document Number: 539403
Highly effective H. pylori eradication therapies are currently used in Japan. However, eradication failures still appear in a considerable proportion of cases. In such refractory cases, several second-line eradication therapies and therapeutic efficacies have been only exceptionally studied. Our aims were to analyze the reasons and evaluate the second-line therapies when first-line eradication therapies fail. We make a strategy for second-line anti-H. pylori therapy in patients with previously failed treatment.

Document emailed within 1 workday
Secure & encrypted payments

Zerbib, F. 1998: Helicobacter pylori et anti-inflammatoires non stéroïdiens Helicobacter pylori et reflux gastro-œsophagien - Helicobacter pylori and NSAID. Helicobacter pylori in GORD Hepato-Gastro (Montrouge) 5(FEV): 56-60
Mincis, M. 1991: Anti-Helicobacter pylori drugs must be considered as first line therapy in peptic ulcer Amb: Revista da Associacao Medica Brasileira 37(1): 51-52
Satoh, K. 2009: Second-line therapy for patients with Helicobacter pylori eradication failure Nihon Rinsho. Japanese Journal of Clinical Medicine 67(12): 2297-2302
Köksal, A.S.; Onder, F.O.ğu.; Torun, S.; Parlak, E.; Sayilir, A.; Tayfur, O.ü; Yildiz, H.; Ozbalci, G.ök.S.çu.; Kayaçetin, E.ğr. 2013: Twice a day quadruple therapy for the first-line treatment of Helicobacter pylori in an area with a high prevalence of background antibiotic resistance Acta Gastro-Enterologica Belgica 76(1): 34-37
Shimamoto, C.; Tokioka, S.; Hirata, I.; Tani, H.; Ohishi, H.; Katsu, K-ichi. 2002: Inhibition of Helicobacter pylori infection by orally administered yolk-derived anti-Helicobacter pylori antibody Hepato-Gastroenterology 49(45): 709-714
Koizumi, W.; Tanabe, S.; Imaizumi, H.; Hibi, K-ichi.; Kida, M.; Ohida, M.; Okayasu, I.; Saigenji, K. 2003: Effect of anti-Helicobacter pylori IgG antibody titer following eradication of Helicobacter pylori infection Hepato-Gastroenterology 50(49): 293-296
Asano, M.; Taniwaki, H.; Tsuji, D.; Sato, Y.; Shimizu, T. 2005: Cytochrome P450 2C19 genotype -based second line therapy with amoxicillin and lansoprazole after failure of initial helicobacter pylori eradication therapy Nihon Rinsho. Japanese Journal of Clinical Medicine 63(Suppl 12): 450-453
Lou, J-gan.; Chen, J.; Huang, X-lei.; Zhao, Z-yan. 2007: Changes in the intestinal microflora of children with Helicobacter pylori infection and after Helicobacter pylori eradication therapy Chinese Medical Journal 120(10): 929-931
Gaidar, I.A.; Stepanova, E.V.; Mosiichuk, L.N.; Demeshkina, L.V.; Sheikhetova, G.A.; Bespalova, E.V.; Kudriavtseva, V.E.; Vcherashniaia, N.N. 2001: Particular features of the relationship of Helicobacter pylori and G cells in patients with duodenal ulcer, with special reference to the Helicobacter pylori strain Likars'ka Sprava 2001(4): 176-177
Jones, R.; Tait, C.; Sladen, G.; Weston-Baker, J. 1999: A trial of a test-and-treat strategy for Helicobacter pylori positive dyspeptic patients in general practice International Journal of Clinical Practice 53(6): 413-416
Gao, W.; Cheng, H.; Hu, F.-l.; Lü, N.-h.; Xie, Y.; Sheng, J.-q.; Xu, J.-m.; Zhang, L.-x.; Zhang, L.; Chen, Y.; Zhang, Z.-y.; Zhang, G.-x.; Cui, M.-h.; Yang, G.-b.; Gao, H.-j.; Yang, L. 2012: Ilaprazole based bismuth-containing quadruple regimen for the first-line treatment of Helicobacter pylori infection: a multicenter, randomized, controlled clinical study Zhonghua Yi Xue Za Zhi 92(30): 2108-2112
Caporali, R.; Epis, O.; Negrini, R.; Scirè, C.A.; Solcia, E.; Montecucco, C. 2003: Salivary gland lymphocytic infiltrates and Helicobacter pylori serology in anti-SSA/Ro positive patients in Italy Clinical and Experimental Rheumatology 21(2): 266-267
Kimura, K.; Ido, K.; Saifuku, K.; Taniguchi, Y.; Kihira, K.; Satoh, K.; Takimoto, T.; Yoshida, Y. 1995: A 1-h topical therapy for the treatment of Helicobacter pylori infection American Journal of Gastroenterology 90(1): 60-63
Chung, S.Jin.; Lee, D.Ho.; Kim, N.; Jung, S.Hyang.; Kim, J.Wook.; Hwang, J.Hyeok.; Park, Y.Soo.; Lee, K.Hyuk.; Jung, H.Chae.; Song, I.Sung. 2007: Eradication rates of helicobacter pylori infection with second-line treatment: non-ulcer dyspepsia compared to peptic ulcer disease Hepato-Gastroenterology 54(76): 1293-1296
Manojlovic, N.; Nikolic, L.; Pilcevic, D.; Josifovski, J.; Babic, D. 2004: Systemic humoral anti-Helicobacter pylori immune response in patients with gastric malignancies and benign gastroduodenal disease Hepato-Gastroenterology 51(55): 282-284
Nakamura, T.; Terano, A. 2002: Eradication therapy of Helicobacter pylori for elderly patients in Japan Nihon Rinsho. Japanese Journal of Clinical Medicine 60(8): 1566-1572
Lugannani, C.; Strickland, C. 1999: Empiric eradication therapy or endoscopy in Helicobacter pylori-positive patients? Journal of Family Practice 48(12): 998
Eliakim, R.; Rachmileweitz, D. 1996: Treatment of Helicobacter pylori positive ulcer--the search for simple and effective therapy Harefuah 131(10): 405-406
Iakovenko, A.V.; Grigor'ev, P.I.; Obukhovskiĭ, B.I.; Mel'nikova, S.V.; Guseĭnova, L.A.; Mardar'eva, S.V.; Agafonova, N.A.; Prianishnikova, A.S.; Soluianova, I.P.; Gioeva, I.Z.; Iakovenko, E.P. 2006: Helicobacter pylori infection in patients with liver cirrhosis: diagnostics and problems of therapy Eksperimental'naia i Klinicheskaia Gastroenterologiia 1: 84-88
Walsh, J.H. 1992: Helicobacter pylori: selection of patients for treatment Annals of Internal Medicine 116(9): 770-771